Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma × daromun × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 1 Carcinoma 1

Interventions

pembrolizumab 3 anlotinib 3 Paclitaxel 3 Cetuximab 3 sintilimab 2 Sorafenib 2 Radiotherapy 2 Leucovorin 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Docetaxel 2 Cisplatin 2 vistusertib 1 titanium silicide 1 tislelizumab 1 tirbanibulin 1 surufatinib 1 regorafenib 1 poly ICLC 1 pemigatinib 1 olaparib 1 durvalumab 1 donafenib 1 daromun 1 avelumab 1 atezolizumab 1 apatinib 1 advexin 1 Therapeutics 1 Temozolomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04362722 2023-10-10

DUNCAN

Philogen S.p.A.

Phase 2 Unknown

Carcinoma, Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡